Literature DB >> 25242303

Modulated electro-hyperthermia enhances dendritic cell therapy through an abscopal effect in mice.

Wei Qin1, Yasunori Akutsu1, Gabor Andocs2, Akiko Suganami3, Xin Hu1, Gulbostan Yusup1, Aki Komatsu-Akimoto1, Isamu Hoshino1, Naoyuki Hanari1, Mikito Mori1, Yuka Isozaki1, Naoki Akanuma1, Yutaka Tamura3, Hisahiro Matsubara1.   

Abstract

The aim of this study was to assess whether modulated electro-hyperthermia (mEHT) can induce an abscopal effect and thereby enhance the antitumor effects of immunotherapy. We used an intratumoral dendritic cell (DC) injection and mEHT to treat C3H/He mice inoculated with squamous cell carcinoma SCCVII cells in the left leg, and we assessed the whole body antitumor effects. Tumors were examined every two or three days in order to assess growth inhibition. The tumor-draining lymph nodes were removed to enable flow cytometric analysis of CD3+ and CD8+ cells, whereas immunohistochemistry was used to assess CD8, S100 and Foxp3 expression in the tumors. Additionally, GP96 expression in the tumors from the different treatment groups was measured. In the control group, the mean tumor volume was larger than that in other groups. These results indicated that the combination therapy of an intratumoral DC injection and mEHT evoked systemic antitumor activity. A larger number of CD3+ and CD8+ cells were detected by flow cytometric analysis in the DC plus mEHT treatment group. Tumor tissue immunostaining showed that CD8 and S100 were more strongly expressed in the DC plus mEHT treatment group, although Foxp3 expression was much higher in the control group. The GP96 gene expression level in the mEHT group was significantly different from the expression level in the control group. An abscopal effect may be induced by mEHT, and the effect of immunotherapy with DCs was strongly enhanced by the overexpression of GP96. GP96 is thought to be one of the molecules explaining the abscopal effect. Direct intratumoral administration of DCs and mEHT may be a feasible future treatment strategy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25242303     DOI: 10.3892/or.2014.3500

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  17 in total

Review 1.  Nanoparticles and nanothermia for malignant brain tumors, a suggestion of treatment for further investigations.

Authors:  Cristina Prieto; Isabel Linares
Journal:  Rep Pract Oncol Radiother       Date:  2018-09-06

2.  Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy.

Authors:  Yuk-Wah Tsang; Cheng-Chung Huang; Kai-Lin Yang; Mau-Shin Chi; Hsin-Chien Chiang; Yu-Shan Wang; Gabor Andocs; Andras Szasz; Wen-Tyng Li; Kwan-Hwa Chi
Journal:  BMC Cancer       Date:  2015-10-15       Impact factor: 4.430

3.  Comparison of biological effects of modulated electro-hyperthermia and conventional heat treatment in human lymphoma U937 cells.

Authors:  G Andocs; M U Rehman; Q-L Zhao; Y Tabuchi; M Kanamori; T Kondo
Journal:  Cell Death Discov       Date:  2016-06-13

4.  Modulated electro-hyperthermia induced loco-regional and systemic tumor destruction in colorectal cancer allografts.

Authors:  Tamas Vancsik; Csaba Kovago; Eva Kiss; Edina Papp; Gertrud Forika; Zoltan Benyo; Nora Meggyeshazi; Tibor Krenacs
Journal:  J Cancer       Date:  2018-01-01       Impact factor: 4.207

5.  In vitro comparison of conventional hyperthermia and modulated electro-hyperthermia.

Authors:  Kai-Lin Yang; Cheng-Chung Huang; Mau-Shin Chi; Hsin-Chien Chiang; Yu-Shan Wang; Chien-Chung Hsia; Gabor Andocs; Hsin-Ell Wang; Kwan-Hwa Chi
Journal:  Oncotarget       Date:  2016-12-20

6.  Modulated electro-hyperthermia induced p53 driven apoptosis and cell cycle arrest additively support doxorubicin chemotherapy of colorectal cancer in vitro.

Authors:  Tamas Vancsik; Gertrud Forika; Andrea Balogh; Eva Kiss; Tibor Krenacs
Journal:  Cancer Med       Date:  2019-06-10       Impact factor: 4.452

7.  Stress-Induced, p53-Mediated Tumor Growth Inhibition of Melanoma by Modulated Electrohyperthermia in Mouse Models without Major Immunogenic Effects.

Authors:  Balázs Besztercei; Tamás Vancsik; Anett Benedek; Enikő Major; Mbuotidem J Thomas; Csaba A Schvarcz; Tibor Krenács; Zoltán Benyó; Andrea Balogh
Journal:  Int J Mol Sci       Date:  2019-08-17       Impact factor: 5.923

Review 8.  Review of the Clinical Evidences of Modulated Electro-Hyperthermia (mEHT) Method: An Update for the Practicing Oncologist.

Authors:  Attila M Szasz; Carrie Anne Minnaar; Gyongyver Szentmártoni; Gyula P Szigeti; Magdolna Dank
Journal:  Front Oncol       Date:  2019-11-01       Impact factor: 6.244

9.  Clinical and economic evaluation of modulated electrohyperthermia concurrent to dose-dense temozolomide 21/28 days regimen in the treatment of recurrent glioblastoma: a retrospective analysis of a two-centre German cohort trial with systematic comparison and effect-to-treatment analysis.

Authors:  Sergey V Roussakow
Journal:  BMJ Open       Date:  2017-11-03       Impact factor: 2.692

Review 10.  Immunogenic Effect of Hyperthermia on Enhancing Radiotherapeutic Efficacy.

Authors:  Sungmin Lee; Beomseok Son; Gaeul Park; Hyunwoo Kim; Hyunkoo Kang; Jaewan Jeon; HyeSook Youn; BuHyun Youn
Journal:  Int J Mol Sci       Date:  2018-09-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.